Janessa Laskin

发表

The cost and cost trajectory of whole‐genome analysis guiding treatment of patients with advanced cancers

Stephen Yip, Deirdre Weymann, Janessa Laskin, 2017, Molecular genetics & genomic medicine.

The Development of a Standardized Software Platform to Support Provincial Population-Based Cancer Outcomes Units for Multiple Tumour Sites: OaSIS - Outcomes and Surveillance Integration System

Sherry Reid, Keith Duncan, John French, 2013, ITCH.

Genomic analysis of a rare human tumor

Inanç Birol, Obi L. Griffith, Steven J. M. Jones, 2010, BMC Bioinformatics.

Whole-genome DNA and RNA sequencing in patients with metastatic colorectal cancer (mCRC).

Stephen Yip, Marco A. Marra, Janessa Laskin, 2014 .

Personalized Oncogenomics: Clinical Experience with Malignant Peritoneal Mesothelioma Using Whole Genome Sequencing

Steven J. M. Jones, Stephen Yip, Marco A. Marra, 2015, PloS one.

Abstract 5287: Heterogeneity of mutation calling and annotation: a survey of cancer next-generation sequencing initiatives by the Global Alliance for Genomics and Health (GA4GH):

Subha Madhavan, Emmanuel Dias-Neto, Thomas J. Hudson, 2016 .

Comparative Tumor RNA Sequencing Analysis for Difficult-to-Treat Pediatric and Young Adult Patients With Cancer

David Haussler, Jingchun Zhu, Katrina Learned, 2019, JAMA network open.

EGFR-directed therapies to treat non-small-cell lung cancer

Janessa Laskin, Cheryl Ho, Cheryl Ho, 2009, Expert opinion on investigational drugs.

Evolution of an adenocarcinoma in response to selection by targeted kinase inhibitors

Steven J. M. Jones, Inanc Birol, Malachi Griffith, 2010, Genome Biology.

Lessons learned from the application of whole-genome analysis to the treatment of patients with advanced cancers

Steven J. M. Jones, Stephen Yip, Marco A. Marra, 2015, Cold Spring Harbor molecular case studies.

Beta-catenin expression is prognostic of improved non-small cell lung cancer survival.

Steven J. M. Jones, Janessa Laskin, Steven J M Jones, 2012, American journal of surgery.